ACCESS DAXXIFY
Live / Applied — Statement of use — registration review complete (as of 13 Sept 2026)
What this means for you
Not registered yet, but its 06 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98256425
- Mark type
- Design + words
- Filed
- 06 Nov 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Maren Perry
Goods and services
- Class 035 — Advertising and business services: Business administration of patient reimbursement programs; Business management of reimbursement programs for others
Owner
- Revance Therapeutics, Inc., Johnson City, TN, US
- Revance Therapeutics, Inc., Newark, CA, US
Prior registrations
Prosecution history
- 13 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — SU - NON-FINAL ACTION - WRITTEN
- 17 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Apr 2025 — USE AMENDMENT FILED
- 17 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jul 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 02 Apr 2025 — ASSIGNED TO EXAMINER